We are live on ! Find out more
CASI

CASI Pharmaceuticals
CASI

Delisted

CASI was delisted on the 25th of February, 2026.

Back to rankings

51 hedge funds and large institutions have $36.4M invested in CASI Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 20 increasing their positions, 11 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

82% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 11

25% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 4

2% more funds holding

Funds holding: 50 → 51 (+1)

0.08% less ownership

Funds ownership: 1.22% → 1.14% (-0.08%)

2% less capital invested

Capital invested by funds: $37.3M → $36.4M (-$895K)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
51
Holders Change
+1
Holders Change %
+2%
% of All Funds
1.12%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
5
Increased
20
Reduced
11
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
WSCM
Wellington Shields Capital Management
New York
+$558K
2
BlackRock
BlackRock
New York
+$397K
3
WG
Winton Group
United Kingdom
+$171K
4
Marshall Wace
Marshall Wace
United Kingdom
+$100K
5
UBS Group
UBS Group
Switzerland
+$89.8K

Top Sellers

1
WSC
Wellington Shields & Co
New York
-$3.6M
2
Charles Schwab
Charles Schwab
California
-$127K
3
AQR Capital Management
AQR Capital Management
Connecticut
-$122K
4
Deutsche Bank
Deutsche Bank
Germany
-$79.7K
5
HF
HRT Financial
New York
-$53K
Name Holding Trade Value Shares
Change 		Change in
Stake
WSC
51
Wellington Shields & Co
New York
– -$3.6M -112,665 Closed
AQR Capital Management
52
AQR Capital Management
Connecticut
– -$122K -3,806 Closed
HF
53
HRT Financial
New York
– -$53K -1,676 Closed
Jane Street
54
Jane Street
New York
– -$35K -1,089 Closed
1 2
3